These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 26140472

  • 1. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.
    Watanabe T, Takase-Minegishi K, Ihata A, Kunishita Y, Kishimoto D, Kamiyama R, Hama M, Yoshimi R, Kirino Y, Asami Y, Suda A, Ohno S, Tateishi U, Ueda A, Takeno M, Ishigatsubo Y.
    Mod Rheumatol; 2016; 26(2):180-7. PubMed ID: 26140472
    [Abstract] [Full Text] [Related]

  • 2. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
    Yonemoto Y, Okamura K, Takeuchi K, Kaneko T, Kobayashi T, Okura C, Tsushima Y, Takagishi K.
    Rheumatol Int; 2016 Jan; 36(1):109-15. PubMed ID: 26232929
    [Abstract] [Full Text] [Related]

  • 3. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
    Chaudhari AJ, Ferrero A, Godinez F, Yang K, Shelton DK, Hunter JC, Naguwa SM, Boone JM, Raychaudhuri SP, Badawi RD.
    Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738
    [Abstract] [Full Text] [Related]

  • 4. Semi-quantitative analysis of 18F fluorodeoxyglucose uptake in the assessment of disease activity and therapeutic response in rheumatoid arthritis: An institutional experience.
    Ravikanth R, Singh JK.
    World J Nucl Med; 2020 Jul; 19(4):347-352. PubMed ID: 33623503
    [Abstract] [Full Text] [Related]

  • 5. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
    Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A.
    Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?
    Karapolat I, Sertpoyraz F, Oncel G, Kobak S, Yalcin M, Kumanlioglu K.
    Nuklearmedizin; 2013 Dec 13; 52(6):244-9. PubMed ID: 24081426
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of 18F-FDG and 18F-NaF PET/CT imaging: A novel semi-quantitative assessment of the effects of age and obesity on hip joint inflammation and bone degeneration.
    Yellanki DP, Kothekar E, Al-Zaghal A, Cheng N, Werner TJ, Høilund-Carlsen PF, Alavi A.
    Hell J Nucl Med; 2018 Dec 13; 21(3):181-185. PubMed ID: 30411728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 18F-FDG and 18F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis.
    Reddy N, Raynor WY, Werner TJ, Baker JF, Alavi A, Revheim ME.
    Diagnostics (Basel); 2023 Jun 23; 13(13):. PubMed ID: 37443544
    [Abstract] [Full Text] [Related]

  • 11. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT.
    Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, Tsushima Y, Takagishi K.
    Rheumatology (Oxford); 2012 Aug 23; 51(8):1484-91. PubMed ID: 22513145
    [Abstract] [Full Text] [Related]

  • 12. Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients.
    Seraj SM, Raynor WY, Revheim ME, Al-Zaghal A, Zadeh MZ, Arani LS, Rojulpote C, Werner TJ, Gerke O, Høilund-Carlsen PF, Baker JF, Alavi A, Hunt SJ.
    Ann Nucl Med; 2020 Jun 23; 34(6):424-431. PubMed ID: 32277422
    [Abstract] [Full Text] [Related]

  • 13. Axillary lymph-node metabolic activity assessment on 18F-FDG-PET/CT in rheumatoid arthritis patients treated with biologic therapies.
    Dam TT, Okamura K, Nakajima T, Yonemoto Y, Suto T, Arisaka Y, Tomonaga H, Tachibana M, Tajika T, Vu LD, Chikuda H, Tsushima Y.
    Scand J Rheumatol; 2020 Mar 23; 49(2):96-104. PubMed ID: 31578102
    [Abstract] [Full Text] [Related]

  • 14. CT-based tissue segmentation to assess knee joint inflammation and reactive bone formation assessed by 18F-FDG and 18F-NaF PET/CT: Effects of age and BMI.
    Al-Zaghal A, Yellanki DP, Ayubcha C, Werner TJ, Høilund-Carlsen PF, Alavi A.
    Hell J Nucl Med; 2018 Mar 23; 21(2):102-107. PubMed ID: 30006643
    [Abstract] [Full Text] [Related]

  • 15. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
    Sachpekidis C, Goldschmidt H, Hose D, Pan L, Cheng C, Kopka K, Haberkorn U, Dimitrakopoulou-Strauss A.
    Eur J Nucl Med Mol Imaging; 2014 Jul 23; 41(7):1343-53. PubMed ID: 24562650
    [Abstract] [Full Text] [Related]

  • 16. [18F]FDG PET/CT in rheumatoid arthritis.
    Graham RN, Panagiotidis E.
    Q J Nucl Med Mol Imaging; 2022 Sep 23; 66(3):234-244. PubMed ID: 36066112
    [Abstract] [Full Text] [Related]

  • 17. Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs.
    Roivainen A, Hautaniemi S, Möttönen T, Nuutila P, Oikonen V, Parkkola R, Pricop L, Ress R, Seneca N, Seppänen M, Yli-Kerttula T.
    Eur J Nucl Med Mol Imaging; 2013 Feb 23; 40(3):403-10. PubMed ID: 23229747
    [Abstract] [Full Text] [Related]

  • 18. Multimodal [18 F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic Mice.
    Hayer S, Zeilinger M, Weiss V, Dumanic M, Seibt M, Niederreiter B, Shvets T, Pichler F, Wadsak W, Podesser BK, Helbich TH, Hacker M, Smolen JS, Redlich K, Mitterhauser M.
    J Bone Miner Res; 2019 Sep 23; 34(9):1632-1645. PubMed ID: 31063606
    [Abstract] [Full Text] [Related]

  • 19. FDG PET Imaging of Extremities in Rheumatoid Arthritis.
    Dhawan R, Lokitz K, Lokitz S, Caldito G, Takalkar AM.
    J La State Med Soc; 2016 Sep 23; 168(5):156-161. PubMed ID: 27797345
    [Abstract] [Full Text] [Related]

  • 20. Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.
    Peterson LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, Jenkins I, Lee JH, Shields A, Montgomery S, Linden HM, Gralow J, Gadi VK, Muzi M, Kinahan P, Mankoff D, Specht JM.
    J Nucl Med; 2018 Dec 23; 59(12):1823-1830. PubMed ID: 29748233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.